Trial Condition(s):

Candidiasis, Vulvovaginal

Clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in 6-day therapy in vaginal candida infections

Bayer Identifier:

Trial_0583

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
42
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information